Singapore-based firm proposes to acquire 25% in Welcure Drugs & Pharma

Welcure Drugs & Pharmaceuticals receives an offer from Telexcell Trade. Telexcell Trade, based in Singapore, plans to acquire a 25 per cent stake. The indicative price is Rs 20 per share. This investment aims to expand Welcure's global presence. The all-cash investment is estimated at Rs 52 crore. Welcure intends to invest in an agro-pharma research lab.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oVTei6H
via IFTTT